Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Shenzhen Vienomics Bio Tech

Shenzhen Vienomics Bio Tech
2016 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$7.23M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of screening technologies intended to reduce the incidence of cancer. The company's technologies are based on ultra-deep gene sequencing technology, bioinformatics analysis and big data analysis which helps in detecting cancer in precancerous lesions or at the early-stage, providing patients with increased chances of survival and reduced mortality rates.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 5th Floor, Building B, Xili Shiwai Taoyuan Creative Park
  • Nanshan District
  • Shenzhen
  • China

+86 0755 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Shenzhen Vienomics Bio Tech’s full profile, request a free trial.

Shenzhen Vienomics Bio Tech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 01-Nov-2018 $7.23M 000.00 Completed Startup
2. Early Stage VC 01-Jan-2017 00.000 00.000 Completed Startup
1. Angel (individual) 01-Jan-2016 $1.55M $1.55M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Shenzhen Vienomics Bio Tech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
AMER International Group Corporation Minority 000 0000 000000 0
Qianjiang Capital Venture Capital Minority 000 0000 000000 0
ASBV China Venture Capital Minority 000 0000 000000 0

Shenzhen Vienomics Bio Tech Executive Team (3)

Name Title Board
Seat
Contact
Info
Chaoyu Liu Ph.D Chief Executive Officer
Peng Chen Chief Financial Officer
Chuanbo Xu Ph.D Chief Medical Officer

Shenzhen Vienomics Bio Tech Board Members (1)

Name Representing Role Since Contact
Info
Jiankui He Ph.D Self Chairman 000 0000